Evolution from mitral annular dysfunction to severe mitral regurgitation in Barlow's disease.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
19 04 2021
Historique:
received: 02 04 2020
revised: 25 10 2020
accepted: 03 11 2020
pubmed: 29 12 2020
medline: 1 10 2021
entrez: 28 12 2020
Statut: ppublish

Résumé

Barlow's disease (BD) is characterized by thick, redundant mitral valve (MV) leaflets, which can lead to prolapse and significant mitral regurgitation (MR). MV annular abnormalities are also commonly observed and increasingly recognized as possible primary pathology, with leaflet thickening being secondary to increased stress on the MV apparatus. To provide more insights into this hypothesis, the evolution of MV abnormalities over time in patients with BD was assessed. A total of 64 patients (54 ± 12 years, 72% male) with BD who underwent MV surgery and had multiple transthoracic echocardiograms (TTE) before surgery were included. In total, 186 TTE were analysed (median time interval 4.2, interquartile range 2.2-6.5 years) including specific MV characteristics. At baseline, MV leaflet length, thickness, billowing height and annular diameter were larger in patients with BD compared to 59 healthy subjects. Systolic outward motion (curling) of the annulus was observed in 77% and severe mitral annular disjunction (≥5 mm) in 38% of patients with BD. Forty (63%) patients had MR grade I-II and 24 (37%) MR grade III-IV; at baseline, the 2 groups only differed in left atrial volume and in thickness and billowing height of the posterior leaflet, showing comparable MV annular abnormalities and dilatation despite different grades of MR. Over time, MV annulus diameter, leaflet length and billowing height increased significantly along with MR grade. In patients with BD, MV annulus abnormalities are present at an early stage and precede the development of significant MR, suggesting their substantial role in the pathophysiology of this disease and as an important target for surgical treatment.

Identifiants

pubmed: 33367628
pii: 6053169
doi: 10.1093/icvts/ivaa304
pmc: PMC8906724
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-514

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Références

Circulation. 1989 Sep;80(3):589-98
pubmed: 2766511
JACC Cardiovasc Imaging. 2017 Dec;10(12):1424-1433
pubmed: 28528161
Circulation. 2002 Sep 10;106(11):1355-61
pubmed: 12221052
J Am Coll Cardiol. 2018 Oct 2;72(14):1610-1612
pubmed: 30261962
Cardiovasc Ultrasound. 2010 Dec 09;8:53
pubmed: 21143934
Circulation. 2016 Apr 26;133(17):1688-95
pubmed: 27006478
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Multimed Man Cardiothorac Surg. 2016 Dec 6;2017:
pubmed: 28106961
Semin Thorac Cardiovasc Surg. 2007 Summer;19(2):90-6
pubmed: 17870001
Am J Cardiol. 2016 Jul 1;118(1):113-20
pubmed: 27184171
J Echocardiogr. 2017 Dec;15(4):176-185
pubmed: 28799132
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442
J Am Soc Echocardiogr. 2005 Oct;18(10):1014-22
pubmed: 16198877
Circ Cardiovasc Imaging. 2015 May;8(5):
pubmed: 25956922
Circulation. 2013 Feb 19;127(7):832-41
pubmed: 23266859
Am J Cardiol. 2008 Mar 1;101(5):662-7
pubmed: 18308017
J Thorac Cardiovasc Surg. 2008 Dec;136(6):1503-9
pubmed: 19114198
Circulation. 2012 Sep 11;126(11 Suppl 1):S183-8
pubmed: 22965981
Circ Cardiovasc Genet. 2017 Oct;10(5):
pubmed: 28993406
J Am Coll Cardiol. 1999 Oct;34(4):1137-44
pubmed: 10520803
Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):176-184
pubmed: 28170033
Eur Heart J. 2010 Aug;31(16):1958-66
pubmed: 20624767
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Circ Cardiovasc Imaging. 2016 Aug;9(8):e005030
pubmed: 27516479
J Am Coll Cardiol. 2018 Oct 2;72(14):1600-1609
pubmed: 30261961
Circulation. 2010 Mar 30;121(12):1423-31
pubmed: 20231533
N Engl J Med. 1986 Feb 27;314(9):535-40
pubmed: 3945291

Auteurs

Yasmine L Hiemstra (YL)

Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.

Anton Tomsic (A)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.

Paola Gripari (P)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Aniek L van Wijngaarden (AL)

Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.

Stéphanie L van der Pas (SL)

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.
Mathematical Institute, Leiden University, Leiden, Netherlands.

Meindert Palmen (M)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.

Robert J M Klautz (RJM)

Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, Netherlands.

Mauro Pepi (M)

Centro Cardiologico Monzino, IRCCS, Milan, Italy.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.

Nina Ajmone Marsan (NA)

Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH